ProfessorSamantha Fraser-Bell

<

Rhine: A Phase III, Multicenter, Randomized, Double-Masked, Active Comparator-Controlled Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Patients With Diabetic Macular Edema2019

Lucerne Phase 3 study to evaluate the efficacy and safety of faricimab in participants with neovascular age related macular degeneration.2019

OAKS: Phase 3 study to compare the efficacy and safety of intravitreal APL-2 therapy with sham injections in patients with geographic atrophy secondary to age-related macular degeneration

GOLDEN: Phase 2 Study to assess safety and efficacy of multiple doses of IONIS-FB-LRx in participants with geographic atrophy secondary to age-related maculardegeneration

Renexus Phase 3 CNTF-Secreting cells for treatment of Macular telangiectasia type 2

Talon: A 64-week, Two-arm, Randomized, Double-masked, Multicenter, Phase IIIb Study Assessing the Efficacy and Safety of Brolucizumab 6 mg Compared to Aflibercept 2 mg ina Treat-to-control Regimen in Patients With Neovascular Agerelated Macular Degeneration (TALON)